Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer.
about
Molecular Targeted Intervention for Pancreatic CancerGemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta-Analysis.Phase II clinical trials on investigational drugs for the treatment of pancreatic cancersConcurrent radiotherapy with S-1 plus cisplatin versus concurrent radiotherapy with cisplatin alone for the treatment of locally advanced cervical carcinoma: a pilot randomised controlled trial.
P2860
Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer.
@en
Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer.
@nl
type
label
Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer.
@en
Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer.
@nl
prefLabel
Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer.
@en
Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer.
@nl
P2093
P2860
P1476
Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
@en
P2093
Choong Kee Park
Dae Ro Choi
Dae Young Zang
Geundoo Jang
Ho Young Kim
Hunho Song
Hyeong Su Kim
Hyo Jung Kim
In-Gyu Kim
P2860
P2888
P304
P356
10.1007/S00280-013-2265-Z
P577
2013-08-27T00:00:00Z